Market Movers:On Friday, the top gainers were Rani Therapeutics Holdings, Inc. (+51.72%), followed by Cabaletta Bio, Inc. (+46.15%). On the contrary NLS Pharmaceutics Ltd. (-93.06%), and Boqii Holding Limited. (-76.43%) declined the most the same day.
Public Service Enterprise GroupNYSE:PEGreported net income of USD 622M, or USD 1.24 per share, for the quarter ended September 30, 2025, compared with USD 520M, or USD 1.04 per share, in the same period of 2024.Non-GAAP operating earnings came in at USD 565M, or …
Adaptimmune Therapeutics PLC (NASDAQ:ADAP) currently holds an average rating of“Reduce”as reported by MarketBeat Ratings. The review is based on evaluations from eight research firms.
Market Movers:On Thursday, the top gainers were Boqii Holding Limited (+113.73%), followed by Charming Medical Limited. (+45.04%). On the contrary FMC Corporation. (-46.52%), and Apellis Pharmaceuticals, Inc. (-31.01%) declined the most the same day.
Silvercrest Asset Management Group Inc.(NASDAQ:SAMG) announced its financial results for the quarter ended September 30, 2025, reporting total assets under management (AUM) of USD 37.6 billion.
Timberland Bancorp, Inc. (NASDAQ:TSBK), the holding company for Timberland Bank, reported a 20% increase innet incometo USD 29.16 million for the fiscal year ended September 30, 2025, compared to USD 24.28 million in the prior year.Earnings per sharerose 22% year-over-year to USD 3.67.
Midland States Bancorp, Inc. (Nasdaq:MSBI) reported net income available to commonshareholdersof USD 5.3 million, or USD 0.24 per diluted share, for the third quarter of 2025. This compares to USD 9.8 million, or USD 0.44 per diluted share, for the second quarter of 2025, …
4D Molecular Therapeutics (Nasdaq:FDMT) announced an exclusive licensing agreement with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of 4D-150 in the Asia-Pacific (APAC) region, including Japan, China, Australia, and other markets.
JPMorgan Chase & Co. reduced its target price forVerizon Communications (NYSE:VZ)from USD 49.00 to USD 47.00. The brokerage reaffirmed a“neutral” ratingon the stock. The report, released Thursday, cited moderate adjustments in market expectations.
As of October 2025, NVIDIA Corporation (NASDAQ:NVDA) stands at the forefront of the global technology market, holding a valuation near USD 4.89 trillion. The company’s shares briefly lifted its capitalization above USD 4.94 trillion after reporting strong earnings, unveiling next-generation AI chips, and securing …